Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03MYV
|
||||
Former ID |
DNC006823
|
||||
Drug Name |
2-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528224] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H21N3
|
||||
Canonical SMILES |
C1CN(CCN1)C(CC2=CC=CC=C2C#N)C3=CC=CC=C3
|
||||
InChI |
1S/C19H21N3/c20-15-18-9-5-4-8-17(18)14-19(16-6-2-1-3-7-16)22-12-10-21-11-13-22/h1-9,19,21H,10-14H2
|
||||
InChIKey |
FCHUPCOGZXEFDS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [528224] | |
Sodium-dependent serotonin transporter | Target Info | Inhibitor | [528224] | ||
KEGG Pathway | Serotonergic synapse | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.